Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-27

Clinical Trial Update: Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia [NA]

View source ↗

Summary

Clinical trial update indicating completion of a study evaluating intermittent theta burst stimulation for negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hôpital le Vinatier | Conditions: Schizophrenia | NA | Status: COMPLETED